Myeloma | Tumor

Elranatamab Elicits Early, Deep Responses in Relapsed/Refractory Myeloma

June 4th 2023

Elranatamab led to early and deep responses in patients with relapsed/refractory myeloma who were previously treated with a BCMA-directed therapy.

Frozen Stem Cell Grafts Linked to Higher Relapse Rates in Blood Cancer

May 18th 2023

Cryopreserved stem cells led to a higher rate of relapse in patients with blood cancer, though there was no difference in survival, research showed.

Marking Off My Cancer Milestones

May 3rd 2023

Mixed in the boxes of appointments and cancer treatments are milestones that uplift my spirits and are unique to my healing journey.

Educated Patient® Multiple Myeloma Summit On the Horizon Panel: April 8, 2023

April 29th 2023

Watch Dr. Brandon J Blue, Dr. Surbhi Sidana, Dr. Kenneth H. Shain and Mary Derome answer questions about the future of treatment during the CURE Educated Patient Multiple Myeloma Summit.

Educated Patient® Multiple Myeloma Summit BiTE and Future Myeloma Directions Presentation: April 8, 2023

April 28th 2023

Watch Dr. Kenneth H. Shain, from Moffitt Cancer Center, discuss the future of myeloma treatment, including BiTE therapy, during the CURE Educated Patient Multiple Myeloma Summit.

Patients With Myeloma Must Recognize the Signs of Cytokine Release Syndrome

April 27th 2023

Patients with myeloma who are being treated with Tecvayli must discuss symptoms of cytokine release syndrome with their providers as soon as they happen.

Educated Patient® Multiple Myeloma Summit CAR T-Cell Therapy Updates Presentation: April 8, 2023

April 27th 2023

Watch Dr. Surbhi Sidana, from Stanford Medicine, discuss CAR-T cell therapy during the CURE Educated Patient Multiple Myeloma Summit.

Educated Patient® Multiple Myeloma Summit Myeloma Management Panel: April 8, 2023

April 26th 2023

Watch Dr. Brandon J Blue, Dr. Dickran Kazandjian and Dr. Marc J. Braunstein answer questions about disease management during the CURE Educated Patient Multiple Myeloma Summit.

Educated Patient® Multiple Myeloma Summit the Role of BMT Presentation: April 8, 2023

April 25th 2023

Watch Dr. Marc Braunstein, from NYU Langone Hospital, discuss the role of bone marrow transplant during the CURE Educated Patient Multiple Myeloma Summit.

Educated Patient® Multiple Myeloma Summit Newly-Diagnosed Updates Presentation: April 8, 2023

April 24th 2023

Watch Dr. Dickran Kazandjian, from Miami Health System, discuss updates in newly diagnosed disease during the CURE Educated Patient Multiple Myeloma Summit.

Educated Patient® Multiple Myeloma Summit Disease Overview Panel: April 8, 2023

April 23rd 2023

Watch Dr. Ariel Grajales-Cruz and Dr. Brandon J Blue answer questions about myeloma during the CURE Educated Patient Multiple Myeloma Summit.

Educated Patient® Multiple Myeloma Summit Health Disparities Presentation: April 8, 2023

April 22nd 2023

Watch Dr. Brandon Blue, from Moffitt Cancer Center, discuss health disparities during the CURE Educated Patient Multiple Myeloma Summit.

Educated Patient® Multiple Myeloma Summit MGUS/Smoldering Myeloma Presentation: April 8, 2023

April 21st 2023

Watch Dr. Ariel F. Grajales-Cruz, from Moffitt Cancer Center, discuss updates in MGUS and smoldering disease during the CURE Educated Patient Multiple Myeloma Summit.

FDA to Review Abecma for Earlier Myeloma Treatment

April 19th 2023

The FDA has accepted a supplemental Biologics License Application for moving up the use of Abecma, a CAR-T cell therapy, for adult patients with multiple myeloma.

FDA Approves Omisirge to Reduce Infection Risk in Patients With Blood Cancer

April 17th 2023

Omisirge is an umbilical cord blood-based therapy that may prevent infection in patients with blood cancer undergoing stem cell transplant.

New Myeloma Treatment Gets Orphan Drug Designation

April 14th 2023

The Food and Drug Administration granted OM-301 an Orphan Drug Designation for the treatment of patients with myeloma.

The COVID-19 Pandemic Broadened Access to Myeloma Experts

April 11th 2023

After the COVID-19 pandemic broadened usage of telehealth, patients with myeloma now have more access to experts in their disease.

MRD Testing Made a Myeloma Survivor Feel ‘OK to Be Safe’

March 22nd 2023

A multiple myeloma survivor discusses how continued minimal residual disease negativity made her feel more confident in coming off of maintenance therapy.

Finding Gratitude in My Myeloma Experience

March 20th 2023

I’m more than six years out from my myeloma diagnosis and realized that I’m capable of more than just surviving.

New Myeloma Therapies Are ‘A Huge Improvement for the Field’

March 17th 2023

Triplet therapy demonstrates improved remission and survival rates, with manageable side effects for patients who are ineligible for transplant.

Onward in the Fight Against Multiple Myeloma

March 3rd 2023

Multiple Myeloma Awareness Month is a time to raise awareness both locally and nationally about efforts to fight myeloma.

Chronic Opioid Use After Stem Cell Transplant May Affect Myeloma Outcomes

February 23rd 2023

Patients who used opioids long-term after undergoing an autologous stem cell transplant tended to have poorer survival outcomes, recent research showed.

Carvykti After Targeted Therapy May ‘Open a Window’ for Patients with Relapsed/Refractory Myeloma

February 16th 2023

Carvykti and other drugs prove that there are still options for patients whose myeloma got worse on prior therapies.

FDA OKs Study of Novel CAR-T Cell Therapy for Myeloma

February 6th 2023

The Food and Drug Administration granted an investigational new drug application and green lit the continued study of GC012F for the treatment of patients with relapsed/refractory myeloma.

The Value of Staying Active During Multiple Myeloma

February 5th 2023

As a part of its Speaking Out Video series, CURE® spoke with Kenny Capps, from Throwing Bones for a Cure, about the importance of staying active during a multiple myeloma diagnosis.

The Weight of Mental Health During Multiple Myeloma

February 5th 2023

As a part of its Speaking Out Video series, CURE® spoke with Kenny Capps, from Throwing Bones for a Cure, about the impact multiple myeloma has on a patient’s mental health and what they can do to help themselves.

The Future of Multiple Myeloma Treatment is Bright and Promising

February 5th 2023

As a part of its Speaking Out Video series, CURE® spoke with Dr. Saad Usmani, on behalf of Throwing Bones for a Cure, about the future of multiple myeloma treatments.

What Does It Mean When Multiple Myeloma Becomes Relapsed/Refractory?

February 5th 2023

Inspired to Reduce Cancer Disparities and Help Those in Need

January 15th 2023

Breaking Barriers for Health Equity

January 14th 2023